Clinical Trial: A Study of ARC-02 in B-cell NHL

U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07691606) titled 'A Study of ARC-02 in B-cell NHL' on June 30.

Brief Summary: This study is to assess safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary efficacy of ARC-02.

Study Start Date: June 04

Study Type: INTERVENTIONAL

Condition: B-cell Non Hodgkin Lymphoma

Intervention: DRUG: ARC-02

Intravenous (IV) infusion.

DRUG: Rituximab

IV infusion.

Recruitment Status: RECRUITING

Sponsor: Taiho Oncology, Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....